feed,title,long_url,short_url
MarketWatch,Allogene Therapeutics stock drops as much as 40% as FDA puts hold on cancer drug study,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/z4E5a2E64ZU/story.aspx,https://on.mktw.net/3FBBVZw
